Birchview Capital’s Qiagen QGEN Stock Holding History

Birchview Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,861	Closed	-$676K	–	51
2019 Q4	$676K	Buy	+18,861	New	+$701K	0.49%	28

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Birchview Capital's QGEN Position: Q1 2020 in Review

Birchview Capital sold out of Qiagen (QGEN) in Q1 2020, closing a stake of 18,861 shares — an estimated $676K sold.

Birchview Capital first reported a position in QGEN in Q4 2019 and held it in 1 quarter. The position peaked at $676K in Q4 2019. 259 funds tracked by Wall St. Rank hold QGEN as of Q1 2020.

Birchview Capital reported no remaining Qiagen position as of Q1 2020 after selling out during the quarter.
Birchview Capital sold 18,861 Qiagen shares in Q1 2020, an estimated $676K.
Birchview Capital first reported a position in Qiagen in Q4 2019 and held it in 1 quarter.
Birchview Capital's Qiagen position peaked at $676K in Q4 2019.
259 funds tracked by Wall St. Rank held Qiagen as of Q1 2020.

Based on Birchview Capital's 13F filing for Q1 2020, filed 12 May 2020.